The BioCanRx vision is to turn all cancers into curable diseases. We invest in leading edge immune oncology research translating world-class technologies from the lab into early phase clinical trials. BioCanRx provides researchers with access to funding, expertise, training and biomanufacturing facilities and is a leader in the translation, manufacture and adoption of cancer immunotherapies.